Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2023 Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2023 Earnings Call Transcript August 2, 2023

Allogene Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $0.59.

Operator: Hello. Thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2023 Conference Call. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be aware that today’s conference is being recorded. I would now...